Permanently removing wheat, barley and rye is the only treatment that works for confirmed celiac disease, its blistering skin form, and gluten-linked balance problems. For everyone else the case is weaker, and the costs — lost whole grain and fibre, poorer substitutes, higher price — are better established. Testing must come first: the tests stop working once gluten is gone. (Full Review)

Protocol

Standard regimen

Lifelong exclusion of wheat, barley, rye

And their derivatives, with contamination below 20 parts per million and daily intake below 10 mg, the level shown not to damage the intestinal lining.

Conventional clinical approach

Dietitian-led strict exclusion

With structured education, championed by the celiac centres at Columbia University and Mayo Clinic and by the Tampere group in Finland.

Integrative alternative

Staged elimination

Wheat first, then barley and rye, with fermentable carbohydrates assessed separately, to distinguish gluten reactivity from fructan reactivity.

Time to effect

Mucosal healing

2–5 years

34% healed at two years, 66% at five; slower and less complete in adults.

Antibody normalisation

6–12 months

Normalisation by 12 months is the usual internal check that exclusion is actually complete.

Digestive symptoms

2–4 weeks

In celiac disease; felt improvement is an unreliable guide to tissue recovery.

Benefits

High: Remission of celiac disease

Medium: Clearance of dermatitis herpetiformis; improvement in cardiovascular risk markers; recovery of bone mineral density in celiac disease; reduced malignancy risk in treated celiac disease

Low: Relief of digestive symptoms without celiac disease; reduction of thyroid antibodies and thyroid-stimulating hormone; improvement in gluten-related neurological dysfunction

Speculative: Reduced intestinal permeability in people without celiac disease; lower innate immune activation from reduced amylase-trypsin inhibitor intake

Contraindications

Suspected but untested celiac disease, until antibody testing and, where indicated, duodenal biopsy are complete on a gluten-containing diet

Current or past restrictive eating disorder, including anorexia nervosa and orthorexia

Adolescents in peak bone accrual (roughly ages 11–18) without a confirmed gluten-related diagnosis and without dietetic supervision

Established osteoporosis (bone mineral density T-score at or below −2.5) without supervised calcium, vitamin D and protein replacement

Food budget or supply that cannot absorb a 139–183% price premium on staples without displacing fruit, vegetables and protein

Wheatgrass, barley grass, brewer's yeast and malt-containing supplements (absolute contraindication in celiac disease)

Key Interactions

Levothyroxine and other narrow-window oral drugs

Drugs and supplements with wheat-derived excipients

Over-the-counter antacids and proton pump inhibitors (omeprazole, esomeprazole)

Iron and calcium supplements

Gut-barrier supplements (glutamine, zinc carnosine, probiotics)

Oral gluten-digesting enzyme products

Low-FODMAP and other elimination diets

Risk & Side Effects

Medium: Loss of whole-grain and cereal-fibre intake; micronutrient and fibre shortfalls; weight gain in those already overweight; loss of diagnostic accuracy if started before testing

Low: Increased arsenic and heavy-metal exposure; persistent cost and access burden; psychological burden and disordered eating

Speculative: Adverse shift in gut microbiota; loss of wheat-derived bioactive compounds

Monitoring

Marker	Target	Why
Tissue transglutaminase IgA	Negative (below assay cut-off) by 12 months	Confirms celiac diagnosis and, later, completeness of exclusion
Total immunoglobulin A	Above 70 mg/dL (age-adjusted)	Detects selective deficiency that makes the primary celiac test falsely negative
Ferritin	50–150 ng/mL (women), 75–200 ng/mL (men)	Iron stores fall with malabsorption and with loss of fortified wheat products
25-hydroxyvitamin D	40–60 ng/mL	Absorption is impaired in active disease and intake falls on the diet at every age
Vitamin B12	500–900 pg/mL	Loss of fortified cereals plus ileal involvement depletes stores
Red blood cell folate	400–800 ng/mL	Gluten-free flours are rarely fortified with folate, unlike wheat flour in many countries
Red blood cell magnesium	4.2–6.8 mg/dL	Intake is insufficient on the diet, particularly in adolescence
High-sensitivity C-reactive protein	Below 1.0 mg/L	Tracks systemic inflammation, which falls as the mucosa heals
Lipid panel with apolipoprotein B	Apolipoprotein B below 80 mg/dL	Captures both the favourable HDL shift and any adverse move from refined gluten-free substitutes
HbA1c	4.8–5.4%	Detects glycaemic drift from refined gluten-free starches replacing whole grain
Bone mineral density (DEXA)	T-score above −1.0	Bone loss is the clinically important consequence of long-standing malabsorption
Urinary or stool gluten immunogenic peptides	Not detected	Objectively verifies exclusion when antibody results and symptoms disagree

Cadence: Baseline before any gluten is removed; 3 months for symptoms and adherence; 6 and 12 months for antibody blood tests and the nutritional panel; every 12 months once stable; bone-density scan every 2–3 years where baseline was abnormal.

Qualitative Assessment

Digestive comfort — bloating, stool form and frequency, and discomfort after meals, scored weekly for the first three months
Energy through the day, particularly the mid-afternoon trough that often accompanies untreated malabsorption
Cognitive clarity and concentration, commonly reported to improve and equally commonly subject to expectation effects
Skin — rash, itch and blistering, the primary response measure in dermatitis herpetiformis
Balance and coordination where transglutaminase 6 antibodies are present
Dietary variety and fibre-rich food count, as a proxy for whether the diet is narrowing
Social and psychological burden of restriction, including avoidance of shared meals

Avoiding Gluten for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment